LONDON--(EON: Enhanced Online News)--According to the latest market study released by Technavio, the global cell culture protein surface coating market is projected to grow to USD 692.4 million by 2021, at a CAGR of more than 13% over the forecast period.
“Animal-derived proteins are collected from the serum of animal blood. It includes bovine calf serum, fetal bovine serum, equine serum, and porcine serum. This segment occupies a majority 35% of the global cell culture protein surface coating market”
This research report titled ‘Global Cell Culture Protein Surface Coating Market 2017-2021’ provides an in-depth analysis of the market in terms of revenue and emerging market trends. This market research report also includes up to date analysis and forecasts for various market segments and all geographical regions.
|Cell culture protein surface coating is a procedure in which the cell culture surfaces are coated with proteins or extracellular matrix (ECM) components to enhance the adhesion and proliferation of the cells during in vitro isolation and cultivation. The ongoing research activities on cell therapy have created a massive demand for cell analysis products, which is acting as a driver for the global cell culture protein surface coating market.|
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.
Based on the product type, the report categorizes the global cell culture protein surface coating market into the following segments:
- Animal-derived protein
- Human-derived protein
- Synthetic protein
- Plant-derived protein
The top three revenue-generating product segments in the global cell culture protein surface coating market are discussed below:
“Animal-derived proteins are collected from the serum of animal blood. It includes bovine calf serum, fetal bovine serum, equine serum, and porcine serum. This segment occupies a majority 35% of the global cell culture protein surface coating market,” says Barath Palada, a lead analyst at Technavio for life science research tools sector.
These proteins have a significant impact in areas of basic and applied research such as drug development and cell analysis. Currently, difficulty in obtaining regulatory approval due to their ethical implications is a factor that is holding back the growth of the market segment.
Human-derived proteins are collected from human blood and are reliable, time-efficient, and scalable to higher scale levels. The advances in recombinant DNA technology provides detailed insights into protein function and structure, which can be exploited in various research studies.
The human-derived proteins are mainly used in developmental research, cell-based therapeutics, and drug/toxicity screening. The use of advanced recombinant versions of human-derived proteins in tissue engineering, cell analysis, drug development, and scaling of vaccines is expected to boost the growth of the market segment further.
“Synthetic proteins are quickly becoming popular in the cell culture protein surface coating market, growing at a CAGR of over 17% through 2021,” says Barath.
Synthetic proteins are very pure and provide efficient and reproducible results, leading to its application in various fields. The growing R&D expenditure of pharma and biotech companies, rising government funding, and adoption of advanced technologies in genome engineering have increased the demand for synthetic biology.
The top vendors highlighted by Technavio’s research analysts in this report are:
- EMD Millipore
- Thermo Fisher Scientific
Browse Related Reports:
- Global Biobanking Market 2017-2021
- Global Genome Engineering Market 2016-2020
- Global Non-Invasive Prenatal Testing Market 2016-2020
Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like central nervous system; in-vitro diagnostics; and infectious and rare diseases. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently.
Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.
Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, resellers, and end-users.
If you are interested in more information, please contact our media team at email@example.com.